Russell Maxwell, MD
Radiation Oncology
Headshot of Russell Maxwell, MD

Russell Maxwell, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman - 2nd Floor
Headshot of Russell Maxwell, MD
Penn Medicine Provider

About me

  • Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

My education and training

  • Johns Hopkins University School of MedicineMedical School
  • Pennsylvania HospitalResidency

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Maxwell is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Lukens JN, Riina MD, Weinstein G, MacDuffie E, Ramkissoon A, Baron J, Berger M, Messing I, Gentile M, Maxwell R, Ojerholm E, Swisher-McClure S, Santos AG, Porier K, Basu D, Brody R, Cannady S, Carey R, Chalian A, Newman J, Rajasekaran K, Rassekh C, Shanti R, Cohen RB, Singh A, Sun L, Montone K, Lin A. Long-Term Results of a Phase 2 Clinical Trial of Radiation Volume and Dose Deintensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma , Int J Radiat Oncol Biol Phys: 2026


Hollawell C, Zhang S, Messing I, Santos AG, Baron J, Friedes C, Min L, Eisenberg R, Khullar K, Maxwell R, Bradley J, Deville C Jr, Metz J, Feigenberg S, Busch T, LaRiviere M Proton Therapy Utilization Among Adult Cancer Patients , Int J Part Ther: 2026


Patel AM, Haleem A, Kaki PC, Lee JJ, Maxwell R, Brant JA, Brody RM, Carey RM Adjuvant radiotherapy in pT3-4N0M0 major salivary gland Cancer without other adverse features , Am J Otolaryngol: 2025


Kaki PC, Patel AM, Revercomb L, Maxwell R, Brant JA, Brody RM, Cannady SB, Carey RM Impact of Facility Volume on Overall Survival in Patients With Head and Neck Cancer Undergoing Palliative Treatment , Am J Hosp Palliat Care: 2025


Kaki PC, Patel AM, Maxwell R, Brant JA, Brody RM, Adappa ND, Palmer JN, Douglas JE, Carey RM Choice of Adjuvant Radiotherapy Facility in Sinonasal Squamous Cell Carcinoma , Laryngoscope, 135(2): 2025,705-715


Huang L, Patel AM, Haleem A, Brant JA, Maxwell R, Brody RM, Carey RM Missed Adjuvant Therapy in Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma , Laryngoscope, 135(2): 2025,729-740


Baron JA, Wright CM, Dreyfuss AD, Chong EA, Svoboda J, LaRiviere MJ, Jones JA, Maity A, Plastaras JP, Paydar I, Maxwell R Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma , Pract Radiat Oncol, 14(5): 2024,e362-e372


Patel AM, Haleem A, Maxwell R, Lukens JN, Lin A, Brody RM, Brant JA, Carey RM Choice of Adjuvant Radiotherapy Facility in Major Salivary Gland Cancer , Laryngoscope: 2024


Patel AM, Haleem A, Maxwell R, Lukens JN, Lin A, Brody RM, Brant JA, Carey RM Choice of Adjuvant Radiotherapy Facility in Major Salivary Gland Cancer , Laryngoscope, 134(8): 2024,3620-3632


Maxwell R, Chang Y, Paul C, Vaughn DJ, Christodouleas JP Cancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma , Adv Radiat Oncol, 8(5): 2023,101259